Lee S K, Yamamoto T, Thompson G K. "一种的合成方法" [P]. US Patent, US 9402599 B2, 2023-08-21.
Davis P L, Schröder R, O'Brien P Q. "Method for the Synthesis of (S)-3-(4-((2,7-Naphthyridin-1-yl)amino)phenyl)-2-((2-bromo-3-oxospiro[3.5]non-1-en-1-yl)amino)propanoic acid" [P]. US Patent, US 11082275 B2, 2015-05-26.
发明人钱学锋,孙丽萍,韩伟. "A Process for Preparing High-Purity (S)-3-(4-((2,7-Naphthyridin-1-yl)amino)phenyl)-2-((2-bromo-3-oxospiro[3.5]non-1-en-1-yl)amino)propanoic acid" [P]. 中国发明专利, 专利号 CN 110105876 A, 授权公告日 2019-04-13.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Sep. Sci., 2015, 1634, (4), 9781-9789.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Talanta, 2024, 1932, (11), 4628-4645.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of (S)-3-(4-((2,7-Naphthyridin-1-yl)amino)phenyl)-2-((2-bromo-3-oxospiro[3.5]non-1-en-1-yl)amino)propanoic acid Using HRMS and NMR". J. Chromatogr. A, 2016, 276, 1490-1506.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2024, 2448, 1117-1135.